Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2004 | 06-2004 | 03-2004 | 09-2003 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 78,711 | N/A | N/A | N/A |
| Receivables | 24,430 | N/A | N/A | N/A |
| Inventories | 7,163 | N/A | N/A | N/A |
| Income taxes - deferred | 30,813 | N/A | N/A | N/A |
| TOTAL | $144,757 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 72,333 | N/A | N/A | N/A |
| Investments And Advances | 244 | 0 | 0 | 0 |
| Intangibles | 28,808 | 0 | 0 | 0 |
| Other Non-Current Assets | 15,724 | 0 | 0 | 0 |
| TOTAL | $117,109 | $N/A | $N/A | $N/A |
| Total Assets | $261,866 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 1,290 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 6,540 | 0 | 0 | 0 |
| Accrued Expenses | 18,720 | N/A | N/A | N/A |
| TOTAL | $64,476 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 13,580 | N/A | N/A | N/A |
| Deferred Revenues | 2,562 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 40,483 | 0 | 0 | 0 |
| TOTAL | $54,063 | $N/A | $N/A | $N/A |
| Total Liabilities | $118,539 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 87 | N/A | N/A | N/A |
| Retained earnings | 125,076 | N/A | N/A | N/A |
| Other shareholders' equity | -30,567 | 0 | 0 | 0 |
| TOTAL | $143,327 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $261,866 | $0 | $0 | $0 |